KUKJEON PHARMACEUTICAL Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 2, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	150,642	306,192	324,839	537,308
Market Cap Growth	-28.61%	-5.74%	-39.54%	-
Enterprise Value	169,209	319,290	284,635	-
Last Close Price	3070.00	6222.17	6590.26	10900.81
PE Ratio	87.71	63.47	36.30	133.06
PS Ratio	1.12	2.51	3.13	6.30
PB Ratio	1.61	3.14	3.52	6.46
P/TBV Ratio	2.19	3.22	3.60	6.50
P/OCF Ratio	16.96	-	-	176.63
EV/Sales Ratio	1.24	2.62	2.75	-
EV/EBITDA Ratio	31.25	33.11	57.72	-
EV/EBIT Ratio	120.85	49.05	81.60	-
Debt / Equity Ratio	0.77	0.81	0.64	0.09
Debt / EBITDA Ratio	11.24	8.17	12.03	1.09
Asset Turnover	0.59	0.58	0.68	-
Inventory Turnover	4.28	4.05	4.62	-
Quick Ratio	0.93	0.94	1.67	2.72
Current Ratio	1.17	1.24	2.02	3.52
Return on Equity (ROE)	5.83%	4.95%	10.12%	-
Return on Assets (ROA)	0.54%	1.93%	1.44%	-
Return on Capital (ROIC)	0.72%	2.48%	1.80%	-
Return on Capital Employed (ROCE)	1.60%	5.20%	2.80%	7.20%
Earnings Yield	1.15%	1.58%	2.76%	0.75%
FCF Yield	1.44%	-14.46%	-9.02%	-1.37%
Dividend Yield	0.32%	0.16%	-	-
Payout Ratio	28.26%	-	5.48%	-
Buyback Yield / Dilution	4.23%	4.23%	-16.16%	-
Total Shareholder Return	4.55%	4.39%	-16.16%	-

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.